Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14328602 | 0.83 | ALDH1A1 (0.39) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL7810255 | 0.80 | NPC1 (0.38) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL2608303 | 0.79 | TSHR (0.41) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL10308349 | 0.78 | NPC1 (0.37) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL2909899 | 0.78 | PAM (0.40) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL30900867 | 0.76 | NPC1 (0.36) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL27221230 | 0.76 | NPC1 (0.36) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL9906060 | 0.76 | ALOX15 (0.36) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL8426224 | 0.76 | NPC1 (0.40) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL887066 | 0.76 | PAM (0.39) | NPC1ALDH1A1LMNATDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130216723-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2013-08-22 | — | — | US | claimed |
| US-8431730-B2 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES (US) | 2013-04-30 | — | — | US | claimed |
| EP-2203519-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | King Industries (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES | 2009-04-23 | — | — | US | claimed |
| WO-2009045466-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2009-04-09 | — | — | WO | claimed |
| US-4477618-A | CROSSLINKING AN ACTIVE HYDROGEN-CONTAINING RESIN BLEND BY BAKING; STORAGE STABILITY | PPG INDUSTRIES, INC. (US) | 1984-10-16 | — | — | US | claimed |
| US-4477618-A | CROSSLINKING AN ACTIVE HYDROGEN-CONTAINING RESIN BLEND BY BAKING; STORAGE STABILITY | PPG INDUSTRIES, INC. (US) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | ORAI1, SARAF, NAPA | NPC1 4439/4885ALDH1A1 3647/4885LMNA 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.